2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid

C90H125N23O21S — CID 121386664

IUPAC2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid
SMILES[H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCOC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O
InChIInChI=1S/C90H125N23O21S/c1-9-10-23-72-89(133)110(6)69(30-34-134-8)82(126)101-60(22-15-31-95-90(92)93)78(122)108-68(77(121)98-44-73(91)116)46-135-47-74(117)100-64(36-51-26-28-55(115)29-27-51)85(129)109(5)50(4)76(120)104-66(40-75(118)119)88(132)113-33-17-25-71(113)84(128)103-62(39-54-43-94-48-99-54)80(124)105-63(35-49(2)3)87(131)112-32-16-24-70(112)83(127)102-61(37-52-41-96-58-20-13-11-18-56(52)58)79(123)107-67(45-114)81(125)106-65(86(130)111(72)7)38-53-42-97-59-21-14-12-19-57(53)59/h11-14,18-21,26-29,41-43,48-50,60-72,96-97,114-115H,9-10,15-17,22-25,30-40,44-47H2,1-8H3,(H2,91,116)(H,94,99)(H,98,121)(H,100,117)(H,101,126)(H,102,127)(H,103,128)(H,104,120)(H,105,124)(H,106,125)(H,107,123)(H,108,122)(H,118,119)(H4,92,93,95)/t50-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70+,71-,72-/m0/s1
InChIKeyAEDQGPHAXVISIP-QDEOZVPMSA-N
MW1897.20 g/mol
LogP-2.45
Rot. Bonds26

About 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid

2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid (PubChem CID 121386664) has the molecular formula C90H125N23O21S and a molecular weight of 1897.20 g/mol. Its IUPAC name is 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid.

Molecular Properties

Compound Name2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid
PubChem CID121386664
Molecular FormulaC90H125N23O21S
Molecular Weight1897.20 g/mol
Exact Mass1895.91
IUPAC Name2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid
SMILES[H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCOC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O
InChIInChI=1S/C90H125N23O21S/c1-9-10-23-72-89(133)110(6)69(30-34-134-8)82(126)101-60(22-15-31-95-90(92)93)78(122)108-68(77(121)98-44-73(91)116)46-135-47-74(117)100-64(36-51-26-28-55(115)29-27-51)85(129)109(5)50(4)76(120)104-66(40-75(118)119)88(132)113-33-17-25-71(113)84(128)103-62(39-54-43-94-48-99-54)80(124)105-63(35-49(2)3)87(131)112-32-16-24-70(112)83(127)102-61(37-52-41-96-58-20-13-11-18-56(52)58)79(123)107-67(45-114)81(125)106-65(86(130)111(72)7)38-53-42-97-59-21-14-12-19-57(53)59/h11-14,18-21,26-29,41-43,48-50,60-72,96-97,114-115H,9-10,15-17,22-25,30-40,44-47H2,1-8H3,(H2,91,116)(H,94,99)(H,98,121)(H,100,117)(H,101,126)(H,102,127)(H,103,128)(H,104,120)(H,105,124)(H,106,125)(H,107,123)(H,108,122)(H,118,119)(H4,92,93,95)/t50-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70+,71-,72-/m0/s1
InChIKeyAEDQGPHAXVISIP-QDEOZVPMSA-N
XLogP-2.45
TPSA644.79 Ų
H-Bond Donors20
H-Bond Acceptors23
Rotatable Bonds26
Heavy Atoms135
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001897.20
LogP ≤ 5-2.45
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid?
The IUPAC name of 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid (CID 121386664) is 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid.
What is the SMILES notation for 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid?
The canonical SMILES for 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid is [H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](CCOC)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H](C(=O)NCC(N)=O)NC1=O.
What is the InChIKey of 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid?
The InChIKey is AEDQGPHAXVISIP-QDEOZVPMSA-N. The full InChI is InChI=1S/C90H125N23O21S/c1-9-10-23-72-89(133)110(6)69(30-34-134-8)82(126)101-60(22-15-31-95-90(92)93)78(122)108-68(77(121)98-44-73(91)116)46-135-47-74(117)100-64(36-51-26-28-55(115)29-27-51)85(129)109(5)50(4)76(120)104-66(40-75(118)119)88(132)113-33-17-25-71(113)84(128)103-62(39-54-43-94-48-99-54)80(124)105-63(35-49(2)3)87(131)112-32-16-24-70(112)83(127)102-61(37-52-41-96-58-20-13-11-18-56(52)58)79(123)107-67(45-114)81(125)106-65(86(130)111(72)7)38-53-42-97-59-21-14-12-19-57(53)59/h11-14,18-21,26-29,41-43,48-50,60-72,96-97,114-115H,9-10,15-17,22-25,30-40,44-47H2,1-8H3,(H2,91,116)(H,94,99)(H,98,121)(H,100,117)(H,101,126)(H,102,127)(H,103,128)(H,104,120)(H,105,124)(H,106,125)(H,107,123)(H,108,122)(H,118,119)(H4,92,93,95)/t50-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70+,71-,72-/m0/s1.
What are the key properties of 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid?
2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid has a molecular weight of 1897.20 g/mol, XLogP of -2.45, 26 rotatable bonds, 20 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3S,6S,9S,15S,18S,21S,27R,30S,33S,36S,39S,42S,45S,48R)-27-[(2-amino-2-oxoethyl)carbamoyl]-36-butyl-30-(3-carbamimidamidopropyl)-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-6-(1H-imidazol-5-ylmethyl)-39,45-bis(1H-indol-3-ylmethyl)-33-(2-methoxyethyl)-18,19,34,37-tetramethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontan-15-yl]acetic acid is sourced from PubChem (CID 121386664), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).